Patients taking medications for bipolar disorder are more prone to metabolic syndrome than Korea's general population

Medical burden in bipolar disorder: findings from the Clinical and Health Outcomes Initiative in Comparative Effectiveness for Bipolar Disorder study (Bipolar CHOICE)

“…Finally, medications prescribed for bipolar disorder, such as mood stabilizers and antipsychotics, were associated with low HDL and high triglyceride levels, as expected given that these medications are typically associated with risk factors for cardiovascular disease . Yet, other parameters (e.g., hypertension, hyperlipidemia, and diabetes) were not associated with these medications.…”

“…It is also associated with increased costs of medical care and loss of productivity , worse course of bipolar illness (i.e., more episodes, longer duration of episode, and poor functioning) , and higher rates of treatment with psychotropic medications . Moreover, medications commonly prescribed to treat bipolar disorder can exacerbate risks of metabolic disturbances and cardiovascular disease .…”

Metabolic syndrome in psychiatry: advances in understanding and management

“…The prevalence of metabolic syndrome in bipolar disorder has been estimated to be between 25 and 27% (Lee 2010). The aetiological factors for metabolic disturbances in people with bipolar disorder are multifactorial.…”

Comparison of the prevalence of metabolic syndrome in patients with schizophrenia and bipolar disorder: a cross-sectional study from Black Sea region

“…However, research comparing these disorders is relatively scarce with inconsistent findings. 26,27 This study aimed to evaluate the prevalence of MetS and its components among patients with schizophrenia and bipolar disorder comparatively in addition to their associations with socio-demographic and clinical characteristics. To the best our knowledge this is the first study comparing the MetS prevalence in schizophrenia and bipolar patients within a Turkish population.…”